Show simple item record

dc.contributor.authorCalitz, Carlemi
dc.contributor.authorHamman, Josias H.
dc.contributor.authorGouws, Chrisna
dc.contributor.authorFey, Stephen J.
dc.contributor.authorWrzesinski, Krzysztof
dc.date.accessioned2018-03-14T11:55:28Z
dc.date.available2018-03-14T11:55:28Z
dc.date.issued2018
dc.identifier.citationCalitz, C. et al. 2018. Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspective. Toxicology mechanisms and methods, 28(5):369-385. [https://doi.org/10.1080/15376516.2017.1422580]en_US
dc.identifier.issn1537-6516
dc.identifier.issn1537-6524 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/26587
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1080/15376516.2017.1422580
dc.identifier.urihttps://doi.org/10.1080/15376516.2017.1422580
dc.description.abstractThe liver is a vital organ fulfilling a central role in over 500 major metabolic functions, including serving as the most essential site for drug biotransformation. Dysfunction of the drug biotransformation processes may result in the exposure of the liver (and other organs) to hepatotoxins, potentially interacting with cellular constituents and causing toxicity and various lesions. Hepatotoxicity can be investigated on a tissue, cellular and molecular level by employing various in vivo and in vitro techniques, including novel three-dimensional (3 D) cell culturing methods. This paper reflects on the liver and its myriad of functions and the influence of drug biotransformation on liver dysfunction. Current in vivo and in vitro models used to study liver function and dysfunction is outlined, emphasizing their advantages and disadvantages. The advantages of novel in vitro 3 D cell culture models are discussed and the possibility of novel models to bridge the gap between in vitro and in vivo models is explained. Progression made in the field of cell culturing methods such as 3 D cell culturing techniques over the last decade promises to reduce the use of in vivo animal models in biotransformation and toxicological studies of the liveren_US
dc.language.isoenen_US
dc.publisherTaylor & Francisen_US
dc.subject3D modelsen_US
dc.subjectDrug biotransformationen_US
dc.subjectDrug toxicityen_US
dc.subjectIn vitro modelsen_US
dc.subjectLiver dysfunctionen_US
dc.titleRecent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspectiveen_US
dc.typeArticleen_US
dc.contributor.researchID20743149 - Calitz, Carlemi
dc.contributor.researchID10081097 - Hamman, Josias Hendrik
dc.contributor.researchID12450960 - Gouws, Chrisna


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record